Literature DB >> 25043947

Development of a sensitive LC-MS/MS method for simultaneous quantification of eleven constituents in rat serum and its application to a pharmacokinetic study of a Chinese medicine Shengmai injection.

Shuyu Zhan1, Qing Shao, Xiaohui Fan, Zheng Li.   

Abstract

A sensitive LC-MS/MS method was developed and validated for simultaneous quantification of 11 constituents, ginsenoside Rg1, Re, Rf, Rg2, Rb1, Rd, Rc, ophiopogonin D, schisandrin, schisandrol B and schizandrin B, in rat serum using digoxin as the internal standard (IS). The serum samples were pretreated and extracted with a two-step liquid-liquid extraction. Chromatographic separation was achieved on a C18 analytical column with a proper gradient elution using 0.02% acetic acid aqueous solution and 0.02% acetic acid-acetonitrile as mobile phase at a flow rate of 0.5 mL/min. MS detection was performed using multiple reaction monitoring via an electrospray ionization source. Good linearity was observed in the validated concentration range for every analyte (r(2) ≥0.9929), and the lower limits of quantitation of the analytes were in the range of 0.044-1.190 ng/mL in rat serum. Intra- and inter-day precisions were <14.2%. The accuracy expressed as recovery was within the range of 85.1-112.8%. The extraction recoveries were >75.8%.The validated method was successfully applied to a pharmacokinetic study of all analytes in rats after single intravenous administration of Shengmai injection.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; Shengmai injection; ginsenoside; lignan; ophiopogonin; pharmacokinetics

Mesh:

Substances:

Year:  2014        PMID: 25043947     DOI: 10.1002/bmc.3273

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  6 in total

1.  Pharmacokinetic Analysis of Four Bioactive Iridoid and Secoiridoid Glycoside Components of Radix Gentianae Macrophyllae and Their Synergistic Excretion by HPLC-DAD Combined with Second-Order Calibration.

Authors:  Tian-Ming Yang; Yang-Xi Liu; Hai-Yan Fu; Wei Lan; Han-Bo Su; He-Bin Tang; Qiao-Bo Yin; He-Dong Li; Li-Ping Wang; Hai-Long Wu
Journal:  Nat Prod Bioprospect       Date:  2017-11-25

2.  Ophiopogon Polysaccharide Promotes the In Vitro Metabolism of Ophiopogonins by Human Gut Microbiota.

Authors:  Huai-You Wang; Shu-Chen Guo; Zhi-Tian Peng; Cheng Wang; Ran Duan; Tina T X Dong; Karl W K Tsim
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

3.  In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity.

Authors:  Peng Zhou; Ge Gao; Chun-Chun Zhao; Jing-Ya Li; Jian-Fei Peng; Shu-Shu Wang; Rui Song; Hui Shi; Liang Wang
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.503

4.  Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC-MS/MS Method.

Authors:  Chi-Lin Li; Yung-Yi Cheng; Chen-Hsi Hsieh; Tung-Hu Tsai
Journal:  Molecules       Date:  2018-01-15       Impact factor: 4.411

5.  Ginsenoside Rb1 and Rd Remarkably Inhibited the Hepatic Uptake of Ophiopogonin D in Shenmai Injection Mediated by OATPs/oatps.

Authors:  Xiaopei Liu; Lin Chen; Mingyi Liu; Hong Zhang; Shibo Huang; Yuqing Xiong; Chunhua Xia
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

6.  A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats.

Authors:  Ninghua Jiang; Bohong Zheng; Yihan Feng; Lei Yin; Yuanrong Liu; Lujing Cao; Ning Zheng; Suxiang Wu; Baoyue Ding; Xuan Huang; Jeffrey Wang; Shuyu Zhan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.